Fight against cervical cancer Flemish Minister Steven Vanackere Welfare, Public Health and Family.

Slides:



Advertisements
Similar presentations
Progress Against Cervical Cancer. 1980–1989 Progress Against Cervical Cancer 1980– –1984: HPV virus is discovered to cause cervical cancer.
Advertisements

Fight Back Against Cancer: Screening and Early Detection
Update on HPV analysis in the Aberdeen Area Delf Schmidt-Grimminger Assistant Professor The University of South Dakota.
Preventing HPV-Related Cancers
The challenges of coding cancer of unknown primary A survey of registration and reporting practices in the UK, Ireland and Australia Claudia Oehler 1,
Centralized Eligibility For Take Charge! program contracted healthcare providers.
International Symposium on Sexual Violence in Conflict and Beyond Bosnia and Hercegovina – Presentation Palais d’Egmont, Brussels, Belgium June 2006.
Research to Practice NYC Alliance Against Sexual Assault Lynne Stevens, LCSW,BCD Assistant Professor, Boston University Medical School Director, Responding.
The Pearl of Wisdom Campaign to Prevent Cervical Cancer (Insert date and Presenter name) Pearl of Wisdom Campaign to Prevent Cervical Cancer.
MS&E 220 Project Yuan Xiang Chew, Elizabeth A Hastings, Morris Jinhui Zhang Probabilistic Analysis of Cervical Cancer Screening and Vaccination.
The HPV Vaccine: Protecting Girls from Cervical Cancer
Cervical Cancer and HPV
Jennifer S. Smith University of North Carolina Cervical Cancer-Free America Initiative Overview Changing the Dialogue about Cervical.
NATIONAL REPORT ON THE IMPLEMENTATION OF THE EUROPEAN LANGUAGE LABEL BELGIUM Anca Cristina Colibaba, Monica Vlad EuroEd Foundation, Romania
Cervical Cancer and Women Living with HIV: A Call to Action Sethembiso Promise Mthembu ICWSA
Cervical Cancer Screening October What do you know about cervical cancer screening?
Trade Liberalization and Labor Mobility in Europe Radek Stefański, 2007.
January is Cervical Health Awareness Month. Mt. Prospect Health Ministry wants you to know that there’s a lot you can do to prevent cervical cancer.
Strategy Development for Increasing Screening Participation Awareness and Resource Mobilization The Akbaraly Foundation experience.
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
Implementation and Monitoring Session: Realistic Expectations, Misunderstandings and Potential Disappointments.
ADAMOS ADAMOU, MEDICAL ONCOLOGIST MEMBER OF THE EUROPEAN PARLIAMENT.
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
Rural Disparities Reduction Project Georgia Cancer Coalition Healthcare Georgia Foundation Grantee Report February 16, 2006.
Ecdc.europa.eu European Cervical Cancer Summit Meeting Brussels, 22 January 2008 Professor Johan Giesecke Chief Scientist, ECDC ECDC Guidance for the Introduction.
Poster template by ResearchPosters.co.za The efficacy of bivalent and tetravalent HPV vaccination against cervical intraepithelial neoplasia and persistent.
BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.
DISCUSSION. EUROCHIP-2 ACTION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4.
A National Approach to Cancer Control in Canada Remarks by Jeff Lozon, Chair Canadian Partnership Against Cancer.
ADVOCATING FOR POLICY CHANGE By Dr Ali Mzige Director, AMM INTERNATIONAL REPRODUCTIVE AND CHILD HEALTH CLINIC.
What is Health Communication?. Learning Objectives Be able to –Define health communication –Identify examples of health communication.
EUROCHIP-2 ACTIVITY ON CERVICAL CANCER SCREENING BULGARIA.
Routine PSA: Evaluating the Evidence Sheldon Greenfield, MD Health Policy Research Institute University of California, Irvine October 23, 2012.
Reporting women’s attitudes to preventive gynaecological healthcare: survey of more than 6000 women in three European countries EUROGIN February.
MELLANY MURGOR University Of Nairobi. WHY? The WHO and the International Agency for Research on Cancer (IARC) identify Cervical Cancer as the leading.
Cervical cancer screening problems and barriers in Lithuania Presented by Ruta Kurtinaitiene Tallin April 2, 2007.
Detention and Alternatives to Detention in Belgium Geert Verbauwhede, Advisor IDC Europe Regional Workshop on A2D, Brussels, March 2014 Interior.
Supporting tough decisions: linking Health technology assessment (HTA) and national priority setting in Norway Ånen Ringard 1, Berit Mørland 1,2 1 Secretariat.
The HPV Vaccine: Protecting Your Daughter from Cervical Cancer Your questions deserve trusted answers.
“Fit for Work Ireland” The Institute of Physical Therapy & Applied Science Croke Park April 2014 John Church – CEO, Arthritis Ireland.
Caribbean Cervical Cancer Prevention and Control Program By Corey Spellman COMM337.
State of California: Collaborative Efforts to Prepare for the HPV Vaccine Tammy Pilisuk, MPH Unit Chief, Provider Education CDHS Immunization Branch for.
DETERMINE Working document # 4 'Economic arguments for addressing social determinants of health inequalities' December 2009 Owen Metcalfe & Teresa Lavin.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Sustainability. Sustainability has become a major concern in all aspects of economic and financial decision making How sustainable is our society? What.
ENERGY SECURITY AND ENERGY UNION PERSPECTIVES FOR MOLDOVA Main achievement – signing and ratification of the EU-Moldova Association agreement Development.
Workshop 18 th May 2010, Brussels Applying the Value+ model on patient involvement in HTA processes.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
Cost-effectiveness of pneumococcal vaccination for older people: a study in five western European countries Ament A, Baltussen R, Duru G, Rigaud-Bully.
Georgia Comprehensive Cancer Control Program 3/10/2015 Program Monitoring and Evaluation Activities Short-Term Outcomes Long-Term Outcomes Intermediate.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Collaboration with Community Partners to Provide Breast and Cervical Cancer Services to the Underserved University of Texas Health Sciences Center at Tyler.
COLLABORATION WITH COMMUNITY PARTNERS TO PROVIDE BREAST AND CERVICAL CANCER SERVICES TO THE UNDERSERVED Patti Olusola, M.D. 1, Sarah Low, M.D. 1, Michelle.
“Take the Test: Not the Risk” HPV and Cervical Cancer Cervical Cancer is Preventable!
By Beshair Nurhussien, Agnes Nantambi, and Allison Wood
Sayeeda Amber Sayed MBBS MPH Christopher Naugler MD FRCPS
We know what to do: the unfinished agenda and priority next steps
Florida’s Top 5 Causes of Deaths
Overview of the performance indicators recommended by European guidelines for quality assurance in cervical cancer screening Dr. Rasa Vansevičiūtė, Lithuania.
School of Life and Health Sciences, University of Ulster Jordanstown
HPV-Related Disease: Separating Fact From Fiction
Increasing Adolescent Immunization Coverage
Collaborative Efforts in California to Prepare for the HPV Vaccine
Exercise Provider Hesitant Parent
National Cancer Center
The experience of Cervical Cancer
528,000 new cases 266,000 death 90 % of the deaths in LMIC
Dr Timothy Armstrong Coordinator
Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.
Presentation transcript:

Fight against cervical cancer Flemish Minister Steven Vanackere Welfare, Public Health and Family

Cervical cancer Flemish Region: Mortality (2005) and incidence (2003) in numbers Mortality (absolute number) 116 Incidence (absolute number) 356 Mortality/ Incidence ratio0.33 Bruto-incidence/ 10 5 women11.7 Reference: mortality certificates Flemish region and Cancer register foundation

International actions /recommendations: International Agency for Research on Cancer ( WHO). Europe against cancer program. Council recommendation on cancer screening (Europe 2003). Preparing for the introduction of HPV vaccines (WHO 2006). …

Flemish policy: Since 1994:  screening every three years for women years old  Standardisation, follow-up, technical guidelines..  Start implementation in all Flemish provinces (call/recall system) 57% women screened. But serious overscreening and underscreening for part of those women. Actual screening: no longer conform international guidelines, 1 province stopped. There is a clear need for improvement.

Work in progress: Recently a Flemish expertgroup was asked to evaluate and renew the old screening program and to start the preparation of implementing a general vaccinationprogram with HPV vaccine in coöperation with the federal government (RIZIV). Meanwhile the vaccine is already reïmbursed in Belgium (about 10 euro out of pocket price)

Conclusion: Women all over the world are crucial, in all aspects, for family and society. Let us support them as much as policy- makers are able to. Let us make self-empowerment of women and patiënts, a fact in every country and in every community.